Abstract
Presenter will discuss alternative modality options for patients with sickle cell disease, discuss the possible etiologies in this unique disease population, and how different modalities often lead to optimizing functionality.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
